Financials
Financial year 2025
DR. ROSSEEL - DR. WESTERLINCK from Maaseik, company number BE0871031294, closed financial year 2025 with a result of € 359,305 after tax. For that financial year DR. ROSSEEL - DR. WESTERLINCK recorded a gross margin of € 444,271 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 291,893 to € 359,305. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 1.4 million
▲ 22% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 359,305
▲ 23% vs 2024
Profit after tax over the fiscal year.
€ 365,370
▲ 29% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 111,100 paid out
31 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 47,625
▲ € 39,594 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,965
▼ 61% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 62,946
▲ 50% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 383,188 | € 227,472 | € 396,112 | € 444,271 | ▲ 12% |
| Profit after taxes | € 279,681 | € 163,444 | € 291,893 | € 359,305 | ▲ 23% |
| Equity | € 1,062,015 | € 1,074,859 | € 1,123,801 | € 1,372,006 | ▲ 22% |
| Total debts | € 285,711 | € 155,798 | € 285,026 | € 172,716 | ▼ 39% |
| Cash | € 371,333 | € 185,630 | € 284,219 | € 365,370 | ▲ 29% |
| Retained profit | € 1,043,415 | € 1,074,859 | € 1,123,801 | € 1,372,006 | ▲ 22% |
| Dividend | € 218,920 | € 132,000 | € 242,950 | € 111,100 | ▼ 54% |
| Balance sheet total | € 1,347,726 | € 1,230,657 | € 1,408,828 | € 1,544,722 | ▲ 10% |
Key figures of DR. ROSSEEL - DR. WESTERLINCK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about DR. ROSSEEL - DR. WESTERLINCK the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to DR. ROSSEEL - DR. WESTERLINCK?
What happened at DR. ROSSEEL - DR. WESTERLINCK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 359,305 (▲ 23% vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Bree. KBO
- New establishment in Maaseik. KBO
In short
From € 279,681 profit in 2022 to € 359,305 profit in 2025.
Paid € 470,430 in corporate taxes since 2022.
Best year ever: 2025, with € 359,305 profit.
Paid out € 704,970 in dividends to the owners in total.
Management
Behind DR. ROSSEEL - DR. WESTERLINCK are Ann WESTERLINCK and Maarten Rosseel.
Directors
According to the 2025 annual accounts
Ann WESTERLINCK
Director
Maarten Rosseel
Director
Establishments
Establishment units
Physical locations of this company
Diestersteenweg 418
3680 Maaseik
Diestersteenweg 425
3680 Maaseik
Active since 23 December 2004
De Houborn 44
3960 Bree
Active since 1 January 2005
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0871.031.294
- VAT number
- BE 0871.031.294
- Registered office
- Diestersteenweg 418, 3680 Maaseik
- Names & denominations
- DR. ROSSEEL - DR. WESTERLINCK
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 January 2005
- Peppol
- Active · Active since 1 Dec 2025